NOT FOR DISTRIBUTION
Header cover image

Market Cap

US$579.1m

Last Updated

2021/09/20 22:39 UTC

Data Sources

Company Financials +

Executive Summary

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. More Details


Snowflake Analysis

Flawless balance sheet and overvalued.


Similar Companies

Share Price & News

How has SeaSpine Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SPNE is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: SPNE's weekly volatility (8%) has been stable over the past year.


Market Performance


7 Day Return

-4.1%

SPNE

-0.5%

US Medical Equipment

-2.5%

US Market


1 Year Return

11.0%

SPNE

34.6%

US Medical Equipment

33.0%

US Market

Return vs Industry: SPNE underperformed the US Medical Equipment industry which returned 34.6% over the past year.

Return vs Market: SPNE underperformed the US Market which returned 33% over the past year.


Shareholder returns

SPNEIndustryMarket
7 Day-4.1%-0.5%-2.5%
30 Day1.5%0.5%-0.9%
90 Day-28.9%7.6%0.8%
1 Year11.0%11.0%35.5%34.6%35.0%33.0%
3 Year-2.5%-2.5%63.9%60.1%57.6%47.9%
5 Year51.4%51.4%160.4%148.7%120.8%96.7%

Long-Term Price Volatility Vs. Market

How volatile is SeaSpine Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is SeaSpine Holdings undervalued compared to its fair value and its price relative to the market?

1.65x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate SPNE's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate SPNE's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: SPNE is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: SPNE is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SPNE's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SPNE is good value based on its PB Ratio (1.6x) compared to the US Medical Equipment industry average (4.6x).


Future Growth

How is SeaSpine Holdings forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

17.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SPNE is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SPNE is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SPNE is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SPNE's revenue (14.7% per year) is forecast to grow faster than the US market (9.8% per year).

High Growth Revenue: SPNE's revenue (14.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SPNE's Return on Equity is forecast to be high in 3 years time


Past Performance

How has SeaSpine Holdings performed over the past 5 years?

0.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SPNE is currently unprofitable.

Growing Profit Margin: SPNE is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: SPNE is unprofitable, but has reduced losses over the past 5 years at a rate of 0.3% per year.

Accelerating Growth: Unable to compare SPNE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SPNE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (40.5%).


Return on Equity

High ROE: SPNE has a negative Return on Equity (-10.31%), as it is currently unprofitable.


Financial Health

How is SeaSpine Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: SPNE's short term assets ($220.2M) exceed its short term liabilities ($43.6M).

Long Term Liabilities: SPNE's short term assets ($220.2M) exceed its long term liabilities ($15.5M).


Debt to Equity History and Analysis

Debt Level: SPNE is debt free.

Reducing Debt: SPNE has no debt compared to 5 years ago when its debt to equity ratio was 0.3%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SPNE has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: SPNE has sufficient cash runway for 2.7 years if free cash flow continues to reduce at historical rates of 2.9% each year.


Dividend

What is SeaSpine Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SPNE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SPNE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SPNE's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SPNE's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SPNE's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.0yrs

Average management tenure


CEO

Keith Valentine (53 yo)

6.33yrs

Tenure

US$2,093,155

Compensation

Mr. Keith C. Valentine serves as Non-Executive Chair of the Board at Locate Bio Limited since January 5, 2021. He has been the Chief Executive Officer of SeaSpine Holdings Corporation since May 2015 and ha...


CEO Compensation Analysis

Compensation vs Market: Keith's total compensation ($USD2.09M) is about average for companies of similar size in the US market ($USD1.68M).

Compensation vs Earnings: Keith's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: SPNE's management team is seasoned and experienced (6 years average tenure).


Board Members

Experienced Board: SPNE's board of directors are considered experienced (6.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: SPNE insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.9%.


Top Shareholders

Company Information

SeaSpine Holdings Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: SeaSpine Holdings Corporation
  • Ticker: SPNE
  • Exchange: NasdaqGS
  • Founded: 2015
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$579.098m
  • Shares outstanding: 36.40m
  • Website: https://www.seaspine.com

Number of Employees


Location

  • SeaSpine Holdings Corporation
  • 5770 Armada Drive
  • Carlsbad
  • California
  • 92008
  • United States

Listings


Biography

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and i...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/20 22:39
End of Day Share Price2021/09/20 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.